Cargando…
吉西他滨联合长春瑞滨方案治疗复治中国晚期非小细胞肺癌患者的多中心回顾性研究
BACKGROUND AND OBJECTIVE: The aim of this study is to detect the efficacy and toxicity of gemcitabine and vinorelbine (GN as second-line or further-line treatment) in refractory advanced non-small cell lung cancer (NSCLC) patients in China. METHODS: We retrospectively reviewed 53 NSCLC patients trea...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999861/ https://www.ncbi.nlm.nih.gov/pubmed/22989453 http://dx.doi.org/10.3779/j.issn.1009-3419.2012.09.02 |
Ejemplares similares
-
吉西他滨联合长春瑞滨方案一线治疗中国晚期非小细胞肺癌患者的多中心回顾性研究
Publicado: (2012) -
吉西他滨调整方案治疗晚期非小细胞肺癌的Ⅱ期临床试验
Publicado: (2012) -
铂类联合多西他赛或长春瑞滨一线治疗晚期非小细胞肺癌的meta分析
Publicado: (2014) -
长春瑞滨联合奥沙利铂对比长春瑞滨联合顺铂治疗中晚期非小细胞肺癌的系统评价
Publicado: (2010) -
吉西他滨治疗RRM1阴性晚期难治非小细胞肺癌患者1例
Publicado: (2011)